China Money Network
Login
Join

China Growth Capital Co-leads Series A+ Round In Biotech Company InxMed

  • September 4, 2020 — 16:10 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biotech company InxMed has recently raised RMB130 million (US$19 million) in a series A+ round financing co-led by China Growth Capital and a fund... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: